Konferenzen zum Thema Gesundheitssystem und Krankenhausverwaltung in den Vereinigten Staaten (USA)

Wählen Sie ein Land aus
1
FDA Audit, Quality Assurance Practices, Responsibilities and Expectations
27. Feb 2020 • San Francisco, CA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
It is no surprise to anyone who reviews regulatory citations to notice the number of deficiencies cited that are associated with quality systems. Today, the basis for all FDA audits both within the US and internationally is based on the quality systems approach and the six systems that comprise it. Whether the audit is a full or partial audit, the quality system within a company will always be inspected and this seminar will help review what are the expectations and the common areas to be familiar with. As a basis for regulatory audits, the quality system, its procedures and their implementation are reviewed to help verify the level of effectiveness in assuring consistent control and quality of materials, components and final product.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
FDA audit seminar, quality assurance practices, internal audit, vendor audit, third party audit, regulatory audit, CAPA programs, investigations, out of specification (OOS) results, quality system requirements (QSR), FDA 21 CFR parts 210-211 and 820, data integrity
Eintrags-ID:
1324516
2
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
02. Mär 2020 - 03. Mär 2020 • South Easton, MA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production. These guidances also support process improvement and innovation through sound science and risk management. The new Process Validation Guideline/Practice incorporate elements of Process Validation as early as the Research and Development phase, and continues onward through Technology Transfer, into the Phase 1 IND Clinical Trial manufacturing phase, and ultimately into Phase 2 and 3, and then commercial manufacturing.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Scientific-technical conference calendar, conference submission, event submission, banner advert
Eintrags-ID:
1324504
3
The Veterinary Drug Approval Process and FDA Regulatory Oversight
05. Mär 2020 - 06. Mär 2020 • Orlando, FL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
"FDA veterinary drug approval process, center for veterinary medicine, new animal drug application, investigational new animal drug (INAD) file, animal disease diagnostic devices, veterinary medicine regulations, veterinary drug user fees, Agriculture’s Animal and Plant Health Inspection Service, APHIS, NADA, FDA’s rules governing chemistry, animal field study, FDA compliant label, labeling, marketing, advertising, animal feed, veterinary devices, OTC drug products, FDA's product centers, Center for Food Safety and Applied Nutrition (CFSAN), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH), Center for Tobacco Products, Center for Veterinary Medicine (CVM), environmental Impact (EA/CE), container Closure System, stability, Veterinary Clinical Trials, Animal Drug User Fees and Related Fee Waivers, 21 USC, 303 and 307
Eintrags-ID:
1324525
Verwandte Fachgebiete:
4
Navigating through Maze of In-vitro Diagnostics (IVD) Regulations: A systematic approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada
05. Mär 2020 - 06. Mär 2020 • San Diego, Kalifornien, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
In-vitro Diagnostics (IVD) products provide critical information on patient’s health condition, based on which the healthcare provider develops and administers treatment plan. Although IVDs are medical devices, they are regulated under a separate set of regulations in U.S., Europe, and Canada.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
In-vitro Diagnostics, IVD regulations, European IVD regulations, Canadian IVD requirements, US in-vitro diagnostic regulations, IVD labeling requirements, Canadian medical device regulations, content of 510(k), Pre-IDE, IDE and PMA
Eintrags-ID:
1324557
Verwandte Fachgebiete:
5
A Comprehensive View of FDA Regulations for Medical Devices
05. Mär 2020 - 06. Mär 2020 • San Diego, Kalifornien, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Don’t let a common misunderstanding get you into trouble! There is more to the US Medical Device Regulations than Part 820.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
US medical device regulations, FDA medical device compliance best practices, FDA QSR, medical device reports (MDR), Unique Device Identification (UDI), Quality System Inspection Technique (QSIT), FDA inspections, medical device manufacturer, form 483s, warning letters, Part 820, quality management system, quality assurance and quality control, device marketing requirements, CAPA, device design requirements
Eintrags-ID:
1324534
Verwandte Fachgebiete:
6
Preparing for FDA's New Import/Export Trauma in 2020
19. Mär 2020 - 20. Mär 2020 • San Francisco, CA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
The FDA continues to change its import program to better manage new problems and to use new procedures to make the whole process easier. The FDA and U.S. Customs and Border Protection (CBP) are relying more and more on computer programs to expedite the import process. When and how you use these programs can make a big difference in the net profit derived from even a single shipment. The new Voluntary Qualified Importer Program (VQIP) is one such example. Another example is CBP’s and FDA’s implementation of the Automated Commercial Environment (ACE) program became mandatory for importers in 2016. If you fail to correctly use new import procedures and programs, you will be operating under an expensive disadvantage.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
FDA import regulations, FDA’s import legal requirements, U.S. Customs and Border Protection, CBP requirements, FDA warning letter, FDA import program, risk of detention, FDA form 2877, CPB form 3461, medical device affirmations of compliance
Eintrags-ID:
1324588
7
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
23. Mär 2020 - 24. Mär 2020 • San Francisco, CA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Analytical methods should be validated to ensure the reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing or a transfer waiver, if justified. If a laboratory uses an alternative method instead of a compendial method, equivalence or superiority of the alternative method should be demonstrated.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing, FDA inspection, SOPs, FDA and EU compliance, documentation, ICH Q2, USP chapters 220, 1200, 1210, 1220, USP, >, GLP, GCP, GMP, FDA Warning Letters, Part 11, Annex 11, LOD, LOQ, HPLC to UHPLC, INDA, ANDA, NDA submissions, QbD, statistical evaluation, Training by, Analytic Lab workshop
Eintrags-ID:
1324598
8
FDA Recalls - Before You Start, and After You Finish
26. Mär 2020 - 27. Mär 2020 • San Francisco, CA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
FDA's recall authority and program launches you into a project of crisis management. You will learn how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves the identification of the root cause of the recall and how you could or should prevent that problem from happening again. Your corrective and preventive action program (CAPA) and quality assurance functions require a rigorous approach to prevent a chronic history of recalls. Reiterative recalls lead the FDA to the conclusion that, "You don't get it."
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
"FDA Recall, FDA recall classes, FDA recall guidance, FDA recall procedures, regulatory management, CAPA, FDA inspection, Recall Regulations, Mandatory recall actions, 21 C.F.R. Part 810, 21 C.F.R. Part 806
Eintrags-ID:
1324562
9
Managing GMP Compliance and Phase Appropriate GMP Considerations for Virtual Companies
26. Mär 2020 - 27. Mär 2020 • Irvine, CA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
In this two day workshop conference you will learn how GMP applies directly to virtual company operations, how to best structure a quality management system in a virtual company, and a method to decide which procedures are necessary at what points in time. You will also learn best practices for quality agreements and vendor management. In addition, you will learn the current guidance from FDA for application of GMP to the manufacture of Phase 1, 2 and 3 clinical trial materials. Though FDA requirements are the primary emphasis, some discussion of EMA (European) requirements and other venues will also be included.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
phase appropriate gmp, fda gmp workshop, FDA GMP Expectations, Phase I, First-in-Man Clinical Trials, CMC Requirements, IND Study, Raw Material Management, 505(b)(2) Products process Validation, ISO 9001:2015 QMS, Combination Products
Eintrags-ID:
1324561
10
Managing Your FDA Inspection: Before, During and After
02. Apr 2020 - 03. Apr 2020 • Chicago, IL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
The course will cover the factors used by the FDA to schedule inspections. You will learn how to predict what an FDA investigator will do and what they will cover in the inspection. There should be no surprises if you have prepared properly. Firms need to understand the details about inspectional techniques to avoid making new problems for yourself during the inspection. You can save yourself a lot of corporate misery if you know what to do before, during and after an inspection
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
FDA inspection seminar, FDA inspection, FDA 483, FDA warning letter, FDA investigator, FDA law, Regulatory Sanctions used by FDA, Prohibited Acts, Management Responsibility from FDA’s view, FDA Inspection Team, FDA Inspection SOP, FDA Meeting, FDA inspection Scribes, Warning Letter Responses, import alerts, inspection documentation
Eintrags-ID:
1324603
11
Method Development and Validation for Assays Supporting Testing of Biologics
02. Apr 2020 - 03. Apr 2020 • Orlando, FL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Biologics continue to be a steadily growing component of the pharmaceutical industry. The advent of large molecule therapeutics requires a different perspective on the assays needed to support development through preclinical and clinical testing.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Attend this biologics seminar to learn essential concepts related to cell-based potency methods, ELISA, immunogenicity methods, analytical CMC methods, cell culture procedures, immunogenicity methods, and biomarker validation
Eintrags-ID:
1329194
12
Supplier and Contract Manufacturer Management
02. Apr 2020 - 03. Apr 2020 • Orlando, FL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Effective management of suppliers and contract manufacturers is an integral component of a quality management system. Suppliers are an integral part of the supply chain and, therefore, the process of production and delivery should by understood and supplier relationships developed and improved. Supplier failures can increase the cost of poor quality through excess inventory, downtime, additional testing, and customer satisfaction. On the other hand, a significant strategic advantage can be gained by excellent supplier management. One of the seven quality principles of ISO 9001 is to build relationships with suppliers because it is a critical component of sustained success.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Supplier, and, Contract, Manufacturer, Management, ComplianceOnline
Eintrags-ID:
1329254
13
Change Management System
07. Apr 2020 • online, Vereinigte Staaten
Veranstalter:
Compliance4all
Kontakt:
Netzealous LLC,DBA -Compliance4all;     Tel.: [8004479407];     Email: support@compliance4All.com
Themen:
Control Management, Management Systems, FDA, Validation Systems
Eintrags-ID:
1333692
Verwandte Fachgebiete:
14
Implementing an Effective CAPA System
10. Apr 2020 • online, Vereinigte Staaten
Veranstalter:
Compliance4all
Kontakt:
Netzealous LLC,DBA -Compliance4all;     Tel.: [8004479407];     Email: support@compliance4All.com
Themen:
Quality Management System, CAPA, Root Cause Analysis, FDA, Online Training
Eintrags-ID:
1333735
Verwandte Fachgebiete:
15
FDA's Problem with Software Monsters
13. Apr 2020 • online, Vereinigte Staaten
Veranstalter:
Compliance4all
Kontakt:
Netzealous LLC,DBA -Compliance4all;     Tel.: [8004479407];     Email: support@compliance4All.com
Themen:
FDA Guide Lines, Malware Protection, Compliance Training, Learn about Ransomware
Eintrags-ID:
1333722
Verwandte Fachgebiete:
16
Hospital Medicine 2020 — SHM's Annual Conference
15. Apr 2020 - 18. Apr 2020 • San Diego, Kalifornien, Vereinigte Staaten
Veranstalter:
Society of Hospital Medicine
Zusammenfassung:
The SHM Annual Conference is created By Hospitalists, For Hospitalists. and is the “fastest growing conference in healthcare” with thousands of attendees every year and can help put hospitalists' careers on the fast track.
Eintrags-ID:
1247792
Verwandte Fachgebiete:
17
WIN — 20/20 and Beyond: Envisioning the Future of Nursing Research, Practice, and Education
15. Apr 2020 - 18. Apr 2020 • Portland, Oregon, Vereinigte Staaten
Zusammenfassung:
The Western Institute of Nursing (WIN) is an organization that addresses the needs and interests of nurses and students engaged in research, practice, and education in all areas of health care. WIN invites you to submit an abstract in research, project, or methodology and/or theory development/conceptual format to be considered for podium or poster presentation at the 2020 WIN Conference in Portland, Oregon, April 15-18. Papers must be completed by the abstract submission deadline to be eligible for podium presentation either as individual papers or as part of a symposium. In-progress research or projects are eligible for poster presentation. Completed research, projects, and theory development /conceptual papers are also eligible for poster presentation. All abstracts, not to exceed 500 words, are to be submitted using WIN’s abstract submission form. Submissions must be received by 11:59 PM Pacific time on Tuesday, October 15, 2019.
Kontakt:
Tel.: [503/494-0869];     Email: win@ohsu.edu
Themen:
Nursing Research, Nursing Education, Clinical Practice, Public Health
Eintrags-ID:
1261407
Verwandte Fachgebiete:
18
Quality Control Laboratory Compliance - cGMPs and GLPs
16. Apr 2020 - 17. Apr 2020 • Boston, MA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices, GLP, cGMP, Current Good Manufacturing Practices, Lab compliance training, laboratory regulations, lab compliance, quality control laboratory, stability studies, laboratory instruments, laboratory supplies, laboratory investigations
Eintrags-ID:
1324645
19
How to Mitigate Microbials in Purified Water and WFI Water Systems: Theory and Practical Application Details Thoroughly Explained Clearly and Concisely
16. Apr 2020 - 17. Apr 2020 • Newark, NJ, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
This course is a comprehensive training on pharmaceutical water systems encompassing over 15 different course subject and modules. The modules include design, build, installation, validation, regulatory compliance, regulatory audit expectations, documentation expectations, modules on continuous electrodeionization (CEDI), ozone, reverse osmosis (RO), distillation methods, pure steam generation, pretreatment options, microbial mitigation and sanitization methods, raw water and sourced water criteria, instrumentation for both observational and compendial criteria, and automation expectations.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
pharmaceutical water system, pharmaceutical water testing, pharmaceutical water system design, pharmaceutical water system validation, pharmaceutical water sampling, pharmaceutical water system compliance, pharmaceutical water system training, water for injection paradigm, water system training, microbial monitoring, microbial mitigation, pharmaceutical water systems sanitization methods, pharmaceutical water production, pharmaceutical water system compendial criteria
Eintrags-ID:
1329182
20
Beyond NanoEHS Risk Assessments - Leading at the Interface of Science and Business
20. Apr 2020 - 21. Apr 2020 • Orlando, FL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Responsible commercialization of new technologies requires leadership at the interface of science and business. For example, advances in materials and applications require a constant attention to the potential risks for the environment, health, and safety (EHS). The development of nanomaterials over the last fifteen years serves as a useful example of a framework for responsibly commercializing new technologies. This course will provide an overview of how to use a tiered-approach framework for identify and mitigating potential risks during the R&D and product development cycle, while also improving the leadership skills required to develop a culture focused on success.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
"NanoEHS Risk Assessments, NanoEHS, nanomaterial environmental health and safety, advanced material science instrumentation, advanced materials research, measuring nanomaterials
Eintrags-ID:
1329247
21
Building a Vendor Qualification Program for FDA Regulated Industries
20. Apr 2020 - 21. Apr 2020 • Orlando, FL, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
This course will provide detailed explanations and examples for Building a Vendor Qualification Program for FDA Regulated Industry. With today’s pharmaceutical market, raw materials, Active Pharmaceutical Ingredients (API), Containers & Closures, inactive or excipients and other components are being sourced from all over the world. We also have Third Party Manufacturers and outside testing facilities that are part of our supply chains. Building and following a robust vendor qualification Program is essential for pharmaceutical and chemical manufacturers. We must create a procedure, which will be used to remain aware of the compliance status for all of our suppliers. Some raw material components may move from producers to brokers to the end users. In addition, there may be other shippers and wholesalers responsible for moving and holding our raw material components.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Vendor qualification program, vendor requirements, off-site audit checklist, on-site verification form, vendor qualification, basics of quality system, FDA regulations
Eintrags-ID:
1329286
22
NHC 2020 — 2020 NURSING EDUCATION, NURSING AND HEALTHCARE CONFERENCE
22. Apr 2020 - 23. Apr 2020 • Houston, Vereinigte Staaten
Veranstalter:
Innovinc International
Zusammenfassung:
2020 Nursing and Healthcare (NHC-2020) provide invaluable opportunities to extend and strengthen the Nursing and Healthcarecommunity, and our collective body of knowledge.
Kontakt:
Tel.: [14083521010];     Email: maryjane@nhc2020.com
Themen:
Nurse Education, Health Care Systems, Nursing & Healthcare Management, Epidemiology and Public Health, Trauma, Critical Care, Nursing Practice & Safety, Disease Transmission and Outbreak, The Changing role of Modern Nursing, Nursing Leadership, Midwifery Nursing & Women's Health, Pain Management & Preventive Medicine, Improving Patient Education, Care & Outcomes, Nursing Informatics & Technology, Palliative Care & Improving Medication Safety, Advances in Nursing, Primary Care & Administration, Evidence-Based Nursing, Healthcare Informatics Research, Child and Adolescent Mental Health, Globalization and Health, Public Health & Safety, Occupational and Health Safety.
Eintrags-ID:
1305848
23
Latin America – Understanding Regulatory Compliance Requirements Across the Life Science Industry (Pharmaceuticals, Biologics, Medical Devices, IVDs)
23. Apr 2020 - 24. Apr 2020 • San Diego, Kalifornien, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
The Latin America Regulatory compliance requirement training/seminar will cover topics across the full Life-Cycle of Company & Product licensing in the key markets of Latin America. Written Regulations vs. Skillful Negotiation will be explained across every critical topic. The importance of local resources, Agency meetings and knowing how to navigate the regulatory landscape will accelerate country establishment and successful product licensing.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
Latin America regulations, Latin America life sciences regulations, Latam life sciences regulatory requirements, Latin America pharmaceutical regulations, Latin America medical device regulations, Latin America biologics regulations, Argentina life sciences regulations, Argentina medical device regulations, Argentina biologics regulations, Brazil life sciences regulations, Brazil medical device regulations, Brazil biologics regulations, Mexico life sciences regulations, Mexico medical device regulations, Mexico biologics regulations, Latin America clinical requirements, Latin America pre-clinical requirements
Eintrags-ID:
1324668
24
Risk Management in Medical Devices Industry
04. Jun 2020 - 05. Jun 2020 • Boston, MA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Risk management is a mandatory and necessary process during the entire device life. Not only will it help to design and maintain devices efficiently, but it also ensures that the device will be as safe as possible and prevents harms to patients, users, and the environment. Like any process that tries to produce repeatable and consistent results, the risk management process must be clearly understood, including the strengths but also the limitations.By attending this seminar you will learn the main elements of ISO 14971, ISO 13485, IEC62304, IEC62366-1/-2, risk management life cycle steps and benefits, and FDA software reviewers' guidance.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
medical device risk management training, ISO 14971 workshop, ISO 13485, quality system integration, IEC62304, IEC62366-1/-2, risk management life cycle, FDA software reviewers' guidance, SOP framework, risk rating methods, european special requirements, risk management report
Eintrags-ID:
1333770
Verwandte Fachgebiete:
25
Laboratory Inspection and Auditing
23. Sep 2020 • Philadelphia, PA, Vereinigte Staaten
Veranstalter:
Complianceonline
Zusammenfassung:
Quality auditing of pharmaceutical quality control laboratories is an important activity for those performing due diligence or monitoring the performance of a sub-contractor. Besides covering GMP regulations affecting pharmaceutical quality control, this one-day course is designed to provide the non-specialist with the necessary knowledge to understand the quality significance and risk associated with different analytical operations.
Kontakt:
Tel.: [18887172436];     Email: referral@complianceonline.com
Themen:
"Lab safety audit checklist, laboratory audit checklist, chemical laboratory audit checklist, pharmaceutical quality assurance, pharmaceutical guidelines for quality assurance, quality control of drugs, gmp guidelines for pharmaceuticals, laboratory inspection
Eintrags-ID:
1324725


Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 20. Februar 2020